recro_logo.jpg
Recro Pharma Provides Pipeline Update
October 26, 2015 08:00 ET | Recro Pharma, Inc.
IV Meloxicam Advancing to Phase III; Pivotal Trials Expected to Commence in First Quarter 2016 Company Shifts Focus of Dex-IN to Peri-Procedural Pain Indication MALVERN, Pa., Oct. 26, 2015...
recro_logo.jpg
Recro Pharma Appoints Karen A. Flynn to Its Board of Directors
September 10, 2015 13:41 ET | Recro Pharma, Inc.
MALVERN, Pa., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment...
recro_logo.jpg
Recro Pharma Announces Presentations at PAINWeek 2015
September 10, 2015 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment...
recro_logo.jpg
Recro Pharma Reports Second Quarter 2015 Financial Results
August 14, 2015 16:05 ET | Recro Pharma, Inc.
‒ Closed Acquisition of Phase III-Ready IV/IM Meloxicam, Cash Flow Positive Manufacturing/Formulation Business from Alkermes ‒ ‒ Announced Positive Phase II Dex-IN Results...
recro_logo.jpg
Recro Pharma Announces Additional Information for Phase II Clinical Trial of Dex-IN
July 24, 2015 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., July 24, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...
recro_logo.jpg
Recro Pharma Appoints Scott Rizzo as General Manager
July 20, 2015 16:01 ET | Recro Pharma, Inc.
MALVERN, Pa., July 20, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...
recro_logo.jpg
Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN
July 17, 2015 08:00 ET | Recro Pharma, Inc.
MALVERN, Pa., July 17, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...
recro_logo.jpg
Recro Pharma Completes $16 Million Private Financing
July 07, 2015 17:01 ET | Recro Pharma, Inc.
MALVERN, Pa., July 7, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...
recro_logo.jpg
Recro Pharma Announces $16 Million Financing
July 01, 2015 09:15 ET | Recro Pharma, Inc.
MALVERN, Pa., July 1, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...
recro_logo.jpg
Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference
May 28, 2015 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., May 28, 2015 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of...